Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 23.03.2026 2 AIDS Res Hum Retroviruses 1 Am J Epidemiol 1 Blood 1 BMC Cancer 1 Cell 7 Clin Infect Dis 3 HIV Med 7 J Acquir Immune Defic Syndr 1 J Clin Invest 4 J Infect Dis 1 J Virol 1 Lancet 1 Nat Med 1 Nat Rev Immunol 1 PLoS Comput Biol 10 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS Res Hum Retroviruses

1. MAGHSOUDI A, Baneshi MR, Hassanzadeh J
   Estimating the Size of Most-at-Risk Populations for HIV/AIDS Using the Generalized Network Scale-Up Method: A Study in Shiraz, IranIran.
   AIDS Res Hum Retroviruses. 2026 Mar 16:8892229261432847.
   PubMed         Abstract available
   
   
2. 
   Corrigendum to: "Histoplasma capsulatum Not Detected in People with HIV and Systemic Symptoms in Port-au-Prince, Haiti".
   AIDS Res Hum Retroviruses. 2026 Mar 13:8892229261431935.
   PubMed        
   
   

   
   Am J Epidemiol

3. LEE JS, Humes E, Haw NJL, Hogan B, et al
   Harmonizing HIV-1 RNA laboratory measurements in a longitudinal cohort collaboration.
   Am J Epidemiol. 2026 Mar 20:kwag056. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Blood

4. KAULEN LD, Nayak L, Karschnia P, Kraai I, et al
   Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.
   Blood. 2026 Mar 17:blood.2025031869. doi: 10.1182/blood.2025031869.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. MISHRA T, Tripathi S, Stapleton JT, Wu L, et al
   Elevated m(6)A RNA modifications associate with immune dysregulation and cancer in people with HIV-1.
   BMC Cancer. 2026 Mar 21. doi: 10.1186/s12885-026-15874.
   PubMed        
   
   

   
   Cell

6. GENG A, Roy R, Ken M, Li L, et al
   Thermodynamic prediction of RNA cellular activity from sequence via conformational ensembles.
   Cell. 2026 Mar 18:S0092-8674(26)00228-X. doi: 10.1016/j.cell.2026.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. CARSTENS RP, Kapoor Y, Vargo RC, Bhattacharyya A, et al
   Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From Two Open-Label, Phase 1 St
   Clin Infect Dis. 2026 Mar 14:ciag135. doi: 10.1093.
   PubMed         Abstract available
   
   
8. LANDOVITZ RJ, Pinedo Y, Hinestrosa F, Crofoot GE, et al
   Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.
   Clin Infect Dis. 2026 Mar 14:ciag171. doi: 10.1093.
   PubMed         Abstract available
   
   
9. CASADO JL, Vizcarra P, Izuzquiza I, Rodriguez-Dominguez MJ, et al
   Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study.
   Clin Infect Dis. 2026 Mar 17:ciag193. doi: 10.1093.
   PubMed         Abstract available
   
   
10. KOETHE JR, Lake JE, Kantor A, Smeaton L, et al
    A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
    Clin Infect Dis. 2026 Mar 18:ciag196. doi: 10.1093.
    PubMed         Abstract available
    
    
11. DENYER RV, Tate JP, Benator DA, Lim JK, et al
    Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
    Clin Infect Dis. 2026 Feb 24:ciag001. doi: 10.1093.
    PubMed         Abstract available
    
    
12. VISEK C, Dalmat RR, Nalutaaya A, Erisa KC, et al
    Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
    Clin Infect Dis. 2026 Mar 20:ciag019. doi: 10.1093.
    PubMed         Abstract available
    
    
13. SOSSEN B, Martinson N
    "Trace-MTB" on Sputum Xpert Ultra: New Evidence for Interpretation in High-burden Settings.
    Clin Infect Dis. 2026 Mar 20:ciag018. doi: 10.1093.
    PubMed        
    
    

    
    HIV Med

14. ZHANG X, Li C, Zhang Y, Jin Y, et al
    Global, regional, and national burden of HIV among children aged 0-14 years: Estimates and socioeconomic inequalities, 1990-2021.
    HIV Med. 2026 Mar 13. doi: 10.1111/hiv.70223.
    PubMed         Abstract available
    
    
15. NDLELA MG, Vilakati LN, Williams V, Ginindza NM, et al
    Cervical cancer screening adherence following initial HIV testing in Eswatini.
    HIV Med. 2026 Mar 19. doi: 10.1111/hiv.70227.
    PubMed         Abstract available
    
    
16. KARAKOSTA A, Nicholls EJ, Coukan F, Nugent D, et al
    Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United Kingdom.
    HIV Med. 2026 Mar 19. doi: 10.1111/hiv.70222.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

17. LIMAS JA, Raju RY, Lewis KA, Ma A, et al
    Barriers to Initiating HIV Pre-Exposure Prophylaxis Over Time Among Youth Who are at Higher Risk of Acquiring HIV.
    J Acquir Immune Defic Syndr. 2026 Mar 20. doi: 10.1097/QAI.0000000000003870.
    PubMed         Abstract available
    
    
18. PAREDES JL, Matos F, Bemplidaki D, Walia H, et al
    Detectable coronary artery score among people living with HIV with regional, study and population variations: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2026 Mar 20. doi: 10.1097/QAI.0000000000003871.
    PubMed         Abstract available
    
    
19. MACHTINGER EL, Cuca YP, Davis K, Shumway M, et al
    Causes of Death of Women with HIV: Discordance between Interdisciplinary Primary Care Teams and Death Certificates.
    J Acquir Immune Defic Syndr. 2026 Mar 20. doi: 10.1097/QAI.0000000000003869.
    PubMed         Abstract available
    
    
20. KWARA A, Martyn-Dickens C, Sly-Moore E, Enimil A, et al
    Pharmacokinetics of Dolutegravir in Children with HIV with and without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines.
    J Acquir Immune Defic Syndr. 2026 Mar 19. doi: 10.1097/QAI.0000000000003862.
    PubMed         Abstract available
    
    
21. MAHIDA K, Jagtap SR
    Comment on "Dose Determination Trial for Evidence-Based Behavioral Counseling to Improve".
    J Acquir Immune Defic Syndr. 2026 Mar 17. doi: 10.1097/QAI.0000000000003867.
    PubMed        
    
    
22. OWOR M, Baltrusaitis K, DeMarrais P, Frenkel LM, et al
    Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV Exposure.
    J Acquir Immune Defic Syndr. 2026 Mar 16. doi: 10.1097/QAI.0000000000003863.
    PubMed         Abstract available
    
    
23. DASGUPTA S, Tie Y, Crim SM, Espinosa C, et al
    Geographic differences in experiences with HIV stigma among U.S. persons with diagnosed HIV.
    J Acquir Immune Defic Syndr. 2026 Mar 16. doi: 10.1097/QAI.0000000000003865.
    PubMed         Abstract available
    
    

    
    J Clin Invest

24. PACHE L, Bui JK, Klouser LM, Fennessey CM, et al
    Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaques.
    J Clin Invest. 2026;136:e187961.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. SAAVEDRA-CERVERA B, Nguenha D, Chihota V, Yimer G, et al
    Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.
    J Infect Dis. 2026 Mar 17:jiag165. doi: 10.1093.
    PubMed         Abstract available
    
    
26. MATOS JM, Marshall VA, Cornejo Castro EM, Miley WJ, et al
    Kaposi sarcoma herpesvirus (KSHV) subtypes and impact on outcomes in KSHV-associated diseases.
    J Infect Dis. 2026 Mar 18:jiag168. doi: 10.1093.
    PubMed         Abstract available
    
    
27. MANI M, Clipman SJ, Bailey JR, Sterling RK, et al
    Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection.
    J Infect Dis. 2026 Mar 20:jiag181. doi: 10.1093.
    PubMed         Abstract available
    
    
28. BARBEE LA, Zhang S, Golden MR, Khosropour CM, et al
    The Natural History of Mycoplasma genitalium at the Pharynx and Rectum in a Cohort of Men who have Sex with Men: Prevalence, Incidence, Duration and Symptomatology.
    J Infect Dis. 2026 Mar 20:jiag173. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

29. OHKURA S, Osanai H, Shimizu M, Horie M, et al
    Study of retroviral restrictions in a Tadarida bat cell line enlightens specific early blocks and TRIM5 locus multiplication.
    J Virol. 2026 Mar 16:e0192725. doi: 10.1128/jvi.01927.
    PubMed         Abstract available
    
    

    
    Lancet

30. KASUJJA FX, Aikaeli F, Garrib A, van Widenfelt E, et al
    Integrated community-based versus facility-based care for people with HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-COMM): an open-label, multicountry, cluster-randomised trial.
    Lancet. 2026;407:1084-1094.
    PubMed         Abstract available
    
    

    
    Nat Med

31. CERQUEIRA-SILVA T, Boaventura VS, Paixao ES, Sanchez M, et al
    Long-term risk of death after tuberculosis diagnosis and treatment.
    Nat Med. 2026 Mar 19. doi: 10.1038/s41591-026-04294.
    PubMed         Abstract available
    
    

    
    Nat Rev Immunol

32. APPAY V, Yamamoto T, Saez-Cirion A
    Renaissance of antiviral CD8(+) T cell immunity in vaccination and disease.
    Nat Rev Immunol. 2026 Mar 18. doi: 10.1038/s41577-026-01284.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

33. OVERSTI S, Boumasmoud M, Gunthard HF, Sax H, et al
    Fast hospital discharge rates blur within-hospital 'transmission footprint' in bacterial genomes, as showcased with Staphylococcus aureus.
    PLoS Comput Biol. 2026;22:e1013982.
    PubMed         Abstract available
    
    

    
    PLoS One

34. OMBAJO LA, Nkuranga J, Penner J, Kamau EW, et al
    The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol.
    PLoS One. 2026;21:e0330792.
    PubMed         Abstract available
    
    
35. AFAYA A, Awunyo W, Udeoha MA, Kodjo MM, et al
    The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study.
    PLoS One. 2026;21:e0344086.
    PubMed         Abstract available
    
    
36. ORTEGA C, Garcia-Iglesias J, Concha F, Mena F, et al
    Experiences of people living with HIV who have participated in psychological interventions: Protocol for a qualitative meta-analysis.
    PLoS One. 2026;21:e0344798.
    PubMed         Abstract available
    
    
37. KELLY SE, Ajidahun A, Bytelaar S, Ding E, et al
    Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C.
    PLoS One. 2026;21:e0344862.
    PubMed         Abstract available
    
    
38. JISUVEI CS, Kinuthia J, Richardson BA, Srinivasan S, et al
    Association between vaginal washing and group B Streptococcus colonization from periconception through the first trimester of pregnancy in a cohort of Kenyan women.
    PLoS One. 2026;21:e0344736.
    PubMed         Abstract available
    
    
39. WILLIAMS LR, Marongiu A, Filippidis FT, Heinzkill M, et al
    A practical evaluation of statistical methods for the analysis of patient reported outcomes in an observational pharmaceutical study.
    PLoS One. 2026;21:e0344968.
    PubMed         Abstract available
    
    
40. JOHNSON TS, Nanziri L, Gupta AJ, Ggita JM, et al
    Effectiveness of routine tuberculosis education in a high-burden setting: A prospective observational cohort study.
    PLoS One. 2026;21:e0344250.
    PubMed         Abstract available
    
    
41. XIE M, Liu X, Zhang Z, Yu Y, et al
    The dynamic network characteristics of physical, psychological, and cognitive symptoms of people with HIV based on cross-lagged network analysis in China.
    PLoS One. 2026;21:e0340077.
    PubMed         Abstract available
    
    
42. BROOKS RA, Nieto O, Santillan M, Rosenberg-Carlson EP, et al
    Community informed recommendations for a campaign to promote awareness of long-acting injectable PrEP among Latino men who have sex with men.
    PLoS One. 2026;21:e0345564.
    PubMed         Abstract available
    
    
43. HERNANDEZ-IBARRA JA, Mercado-Torres TR, Ruiz-Ruiz JR, Roman-Montes CM, et al
    Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico.
    PLoS One. 2026;21:e0338570.
    PubMed         Abstract available
    
    

    
    Vaccine

44. TROCCOLI CS, Nascimento PS, Villar LM, Miguel JC, et al
    Long-term persistence of Seroprotection following a modified hepatitis B vaccine schedule in people living with HIV.
    Vaccine. 2026;79:128483.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum